MedTrace Logo

Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients

NCT05431491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-05-02

No results posted yet for this study

Summary

To determine the feasibility and safety of deresuscitation using slow continuous ultrafiltration with regional citrate anticoagulation and peripheral or standard central venous access.

Conditions

  • Fluid Overload

Interventions

DEVICE

Ultrafiltration

Ultrafiltration through much smaller intravenous cannula than what has previously been used.

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    lead OTHER

Principal Investigators

  • Jon Silversides, PhD · BHSCT

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-12
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05431491 on ClinicalTrials.gov